
Privia Health (PRVA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
480.1M
Gross Profit
45.8M
9.53%
Operating Income
5.2M
1.09%
Net Income
6.0M
1.26%
EPS (Diluted)
$0.03
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
474.0M
Shareholders Equity
709.5M
Debt to Equity
0.67
Cash Flow Metrics
Operating Cash Flow
-9.3M
Free Cash Flow
-24.1M
Revenue & Profitability Trend
Privia Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.7B | 1.7B | 1.4B | 966.2M | 817.1M |
Cost of Goods Sold | 1.6B | 1.5B | 1.2B | 902.6M | 734.5M |
Gross Profit | 176.9M | 161.5M | 134.8M | 63.7M | 82.6M |
Gross Margin % | 10.2% | 9.7% | 9.9% | 6.6% | 10.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 152.6M | 134.3M | 149.3M | 278.6M | 55.4M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 152.6M | 134.3M | 149.3M | 278.6M | 55.4M |
Operating Income | 17.0M | 20.6M | -19.1M | -217.4M | 25.4M |
Operating Margin % | 1.0% | 1.2% | -1.4% | -22.5% | 3.1% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | 1.1M | 1.9M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 27.9M | 29.0M | -18.6M | -218.5M | 23.5M |
Income Tax | 10.8M | 8.0M | -6.5M | -27.9M | -7.4M |
Effective Tax Rate % | 38.8% | 27.5% | 0.0% | 0.0% | -31.7% |
Net Income | 17.0M | 21.0M | -12.1M | -190.6M | 30.9M |
Net Margin % | 1.0% | 1.3% | -0.9% | -19.7% | 3.8% |
Key Metrics | |||||
EBITDA | 24.2M | 27.2M | -14.6M | -215.0M | 27.2M |
EPS (Basic) | $0.12 | $0.20 | $-0.08 | $-1.83 | $0.30 |
EPS (Diluted) | $0.11 | $0.19 | $-0.08 | $-1.83 | $0.30 |
Basic Shares Outstanding | 119402749 | 116731406 | 110695266 | 102952370 | 102785817 |
Diluted Shares Outstanding | 119402749 | 116731406 | 110695266 | 102952370 | 102785817 |
Income Statement Trend
Privia Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 491.1M | 389.5M | 348.0M | 320.6M | 84.6M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 316.2M | 290.8M | 189.6M | 117.4M | 99.1M |
Inventory | - | - | - | - | - |
Other Current Assets | 27.5M | 20.5M | 14.4M | 8.7M | 6.3M |
Total Current Assets | 834.8M | 700.8M | 552.0M | 446.7M | 190.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 4.8M | 6.6M | 8.1M | 9.6M | 0 |
Goodwill | 393.0M | 385.1M | 311.3M | 315.6M | 243.3M |
Intangible Assets | 109.8M | 107.6M | 57.4M | 59.7M | 6.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 43.5M | 43.8M | 45.1M | 37.9M | 9.4M |
Total Non-Current Assets | 301.0M | 299.1M | 240.9M | 239.7M | 138.9M |
Total Assets | 1.1B | 999.9M | 792.8M | 686.4M | 329.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 9.8M | 7.9M | 6.7M | 3.0M | 5.2M |
Short-term Debt | 2.6M | 3.0M | 3.0M | 3.8M | 875.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 364.6M | 326.1M | 208.4M | 140.7M | 106.8M |
Total Current Liabilities | 449.1M | 387.0M | 264.3M | 190.5M | 146.9M |
Non-Current Liabilities | |||||
Long-term Debt | 3.0M | 5.2M | 8.5M | 42.7M | 32.8M |
Deferred Tax Liabilities | - | - | - | - | 0 |
Other Non-Current Liabilities | 153.0K | 313.0K | 1.0M | 3.0M | 5.6M |
Total Non-Current Liabilities | 3.2M | 5.6M | 9.5M | 45.7M | 38.4M |
Total Liabilities | 452.3M | 392.5M | 273.8M | 236.2M | 185.3M |
Equity | |||||
Common Stock | 1.2M | 1.2M | 1.1M | 1.1M | 960.0K |
Retained Earnings | -179.2M | -193.6M | -216.7M | -208.1M | -19.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 683.4M | 607.4M | 519.0M | 450.2M | 143.7M |
Key Metrics | |||||
Total Debt | 5.6M | 8.3M | 11.5M | 46.5M | 33.7M |
Working Capital | 385.7M | 313.9M | 287.7M | 256.2M | 43.1M |
Balance Sheet Composition
Privia Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 17.0M | 21.0M | -12.1M | -190.6M | 30.9M |
Depreciation & Amortization | 7.3M | 6.5M | 4.6M | 2.5M | 1.8M |
Stock-Based Compensation | 56.7M | 37.1M | 67.4M | 253.5M | 484.0K |
Working Capital Changes | 8.5M | 9.8M | -7.5M | 18.0M | 9.3M |
Operating Cash Flow | 98.3M | 82.0M | 46.0M | 55.1M | 34.9M |
Investing Activities | |||||
Capital Expenditures | - | -113.0K | -104.0K | -547.0K | -380.0K |
Acquisitions | -7.0M | -42.9M | 0 | -32.2M | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -12.0M | -43.0M | -104.0K | -32.8M | -380.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | 0 | 0 |
Debt Repayment | 0 | 0 | -33.2M | -875.0K | -10.9M |
Financing Cash Flow | 1.7M | -5.0M | -33.1M | 209.8M | -10.9M |
Free Cash Flow | 109.3M | 80.7M | 47.1M | 54.5M | 38.5M |
Net Change in Cash | 88.0M | 33.9M | 12.8M | 232.1M | 23.6M |
Cash Flow Trend
Privia Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
192.00
Forward P/E
81.23
Price to Book
3.79
Price to Sales
1.36
PEG Ratio
81.23
Profitability Ratios
Profit Margin
0.78%
Operating Margin
0.64%
Return on Equity
2.71%
Return on Assets
1.04%
Financial Health
Current Ratio
1.65
Debt to Equity
0.91
Beta
0.81
Per Share Data
EPS (TTM)
$0.11
Book Value per Share
$5.57
Revenue per Share
$15.75
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
prva | 2.6B | 192.00 | 3.79 | 2.71% | 0.78% | 0.91 |
Veeva Systems | 45.6B | 59.15 | 7.33 | 14.06% | 27.34% | 1.24 |
Ge Healthcare | 33.5B | 15.04 | 3.45 | 25.80% | 11.22% | 107.67 |
HealthEquity | 7.8B | 65.61 | 3.67 | 5.77% | 9.80% | 52.11 |
Waystar Holding | 6.2B | 64.55 | 1.95 | 2.81% | 8.50% | 39.60 |
BrightSpring Health | 4.0B | 89.76 | 2.62 | 2.67% | 0.52% | 155.46 |
Financial data is updated regularly. All figures are in the company's reporting currency.